A U.K.-based biotechnology company developing targeted cancer therapies using its proprietary Affimer protein platform. The firm’s pipeline focuses on tumor‑activated drug conjugates designed to deliver chemotherapy more selectively, with several candidates in early clinical and preclinical developm...
3 members of Congress have disclosed 3 trades in Avacta Corporation (AVCT), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 3 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2019-01-09 | Donna Shalala | sell | $1K – $15K |
| 2015-11-18 | JOHN K. DELANEY | sell | $1K – $15K |
| 2015-02-05 | Rohit Khanna | sell | $15K – $50K |